News
Not One Vote Was Unanimous
Six peptides got a yes. The widest margin all meeting was three votes. Here is what that actually tells you.
The database · Updated August 2026
Every research peptide, and exactly where it stands.
Not opinions about what these compounds do — there are none here. A record of what a committee decided, what a seller published, and how far any of it goes.
13
Compounds on file
7
Put to the committee
23–24 July 2026
6
Recommended
0
Approved for people
Not one of them
Where every compound sits
By committee standingS
Recommended, widest margin
A
Recommended, narrow margin
B
Not put to the committee
F
Turned down
Ranked by regulatory standing, not by effect — so every place on the board is a matter of public record. The full board.
The vote, in full
7 compounds · 2 daysYes votes as recorded. Not one was unanimous. Every tally and what it changes.
How far a yes vote goes
Step 1 of 4-
✓Panel voteDone
-
2FDA decidesWaiting
-
3Rule writtenNot started
-
4Pharmacy may compoundNot started
Most coverage stopped at step one and called it approval. It is not. What is left.
Explainers
Charts, not essays
News
What The 2023 Decision Did
The 2026 vote was a vote to undo something. This is the something, and what it changed about who stands between a buyer and a jar.
News
Three Steps Left
The panel voted. That was one step of four. Here is the rest, what can stall at each one, and why nobody can honestly give you a date.
News
The One That Lost By A Vote
Seven peptides went to the committee. Emideltide — the compound most people know as DSIP — came out with a no, by a single vote.
Learn
What Is A Peptide?
Your cells pass messages to each other all day. Peptides are those messages. Everything else on this site follows from that one idea.
Research areas
7 fieldsCompounds we hold a record for, by the field they appear in. Appearing in a field means the name turns up in that research. It does not mean the compound does anything.